Global Trends in Heart Disease & Targets for Improvement: Statistics & Epidemiology Update from the American Heart Association

Sunday, March 8, 2026

1:30 PM - 1:38 PM EST

Location: Monroe

Speaker(s)

Seth S. Martin, MD, MHS, FACC, FAHA, FASPC

Professor
Johns Hopkins
Reisterstown, Maryland, United States

Disclosure(s): Amgen, Arrowhead, Chroma, HeartFlow, Kaneka, Merck, NewAmsterdam, Novartis, Pfizer, Sanofi, and Verve Therapeutics: Consulting Fees (e.g., advisory boards) (Ongoing); Corrie Health: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing)

Disclosure(s):

Seth S. Martin, MD, MHS, FACC, FAHA, FASPC: Amgen, Arrowhead, Chroma, HeartFlow, Kaneka, Merck, NewAmsterdam, Novartis, Pfizer, Sanofi, and Verve Therapeutics: Consulting Fees (e.g., advisory boards) (Ongoing); Corrie Health: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing)